A comprehensive view of Women's Health Issues. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.
FDA accepts for priority review GSK’s application for an expanded indication of Jemperli dostarlimab-gxly plus chemotherapy to include all adult patients with primary advanced or recurrent endometrial cancer
Published:
April 24, 2024
by GSK Group (GlaxoSmithKline)
|
MI HB5641: Education: curriculum; health education standards and guidelines; modify to include instruction on fetal development. Amends 1976 PA 451 (MCL 380.1 - 380.1852) by adding sec. 1170c.
Published:
April 23, 2024
by Michigan 102nd Legislature
|
VT S0025: An act relating to regulating cosmetic and menstrual products containing certain chemicals and chemical classes and textiles and athletic turf fields containing perfluoroalkyl and polyfluoroalkyl substances
Published:
April 23, 2024
by Vermont 2023-2024 Session
|
HHS announces a new rule to strengthen privacy protections related to women's reproductive health care; the rule prohibits the disclosure of protected health information related to lawful reproductive health care in certain circumstances
Published:
April 22, 2024
by U.S. Dept. of Health and Human Services (HHS)
|
Eli Lilly and Company Files Taiwan Patent Application for Selective Estrogen Receptor Degraders
Published:
April 20, 2024
by Pharmaceutical Patent News
|
Ask us about our Tissue & Hygiene market view